Calcium folinate pentahydrate
Locally Advanced Pancreatic Neuroendocrine Carcinoma
Roswell Park Cancer InstituteSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Locally Advanced Pancreatic Neuroendocrine Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Irinotecan Roswell Park Cancer Institute | Phase 2 | B |
FLUOROURACILUM Roswell Park Cancer Institute | Phase 2 | CCC |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →